Inventor

TAPSCOTT STEPHEN J

US9 patents

⚠️ This page may combine multiple inventors who share the name “TAPSCOTT STEPHEN J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HUTCHINSON FRED CANCER RES

4 patents

US5795723AAug 18, 1998

Expression of neurogenic bHLH genes in primitive neuroectodermal tumors

HUTCHINSON FRED CANCER RES58 citations95

US5695995ADec 9, 1997

Neurogenic differentiation (neurod) genes

HUTCHINSON FRED CANCER RES38 citations87

US6444463B1Sep 3, 2002

Neurogenic differentiation gene neurod3 and methods for inducing differentiation of cells

HUTCHINSON FRED CANCER RES17 citations82

US5352595AOct 4, 1994

Myod regulatory region

HUTCHINSON FRED CANCER RES18 citations78

IONIS PHARMACEUTICALS INC

1 patent

US10538763B2Jan 21, 2020

Compounds and methods for modulation of DUX4

IONIS PHARMACEUTICALS INC21 citations93

VAN DER MAAREL SILVERE M

1 patent

US10865445B2Dec 15, 2020

Methods for alleviating facioscapulohumeral dystrophy (FSHD) by N siRNA molecule inhibiting the expression of DUX4-FL

VAN DER MAAREL SILVERE M29 citations81

UNIV SAINT LOUIS

1 patent

US9814728B2Nov 14, 2017

Inhibition of DUX4 expression using bromodomain and extra-terminal domain protein inhibitors (BETi)

UNIV SAINT LOUIS8 citations76

FRED HUTCHINSON CANCER CENTER

1 patent

US12458668B2Nov 4, 2025

Methods for treating facioscapulohumeral muscular dystrophy

FRED HUTCHINSON CANCER CENTER0 citations53

TAPSCOTT STEPHEN J

1 patent

US8597880B2Dec 3, 2013

Methods and compositions for identifying increased risk of developing fragile X-associated disorders

TAPSCOTT STEPHEN J0 citations35